, Volume 122, Issue 3-4, pp 20-21

Le terapie farmacologiche nelle fratture da fragilità

Purchase on Springer.com

$39.95 / €34.95 / £29.95*

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Many therapeutic agents are currently available for osteoporotic fractures prevention, and their efficacy has been demonstrated in several clinical studies. Major evidences derive from randomized controlled trials or meta-analyses in which vertebral, non-vertebral and hip antifracture effect was tested. Here we summarize the principal data about drugs currently registered in Italy for the treatment of osteoporosis.